DE60326354D1 - Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form - Google Patents
Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz formInfo
- Publication number
- DE60326354D1 DE60326354D1 DE60326354T DE60326354T DE60326354D1 DE 60326354 D1 DE60326354 D1 DE 60326354D1 DE 60326354 T DE60326354 T DE 60326354T DE 60326354 T DE60326354 T DE 60326354T DE 60326354 D1 DE60326354 D1 DE 60326354D1
- Authority
- DE
- Germany
- Prior art keywords
- dosage form
- transdermal dosage
- free base
- antagonist
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40498002P | 2002-08-20 | 2002-08-20 | |
PCT/US2003/026132 WO2004017941A2 (en) | 2002-08-20 | 2003-08-20 | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60326354D1 true DE60326354D1 (de) | 2009-04-09 |
Family
ID=31946794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60326354T Expired - Lifetime DE60326354D1 (de) | 2002-08-20 | 2003-08-20 | Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040126323A1 (de) |
EP (1) | EP1530469B1 (de) |
JP (3) | JP4642467B2 (de) |
AT (1) | ATE423560T1 (de) |
AU (1) | AU2003268144A1 (de) |
CY (1) | CY1109070T1 (de) |
DE (1) | DE60326354D1 (de) |
DK (1) | DK1530469T3 (de) |
ES (1) | ES2323127T3 (de) |
PT (1) | PT1530469E (de) |
SI (1) | SI1530469T1 (de) |
WO (1) | WO2004017941A2 (de) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1720028A (zh) | 2002-04-23 | 2006-01-11 | 阿尔扎公司 | 降低了滥用可能的经皮止痛系统 |
US7524515B2 (en) * | 2003-01-10 | 2009-04-28 | Mutual Pharmaceuticals, Inc. | Pharmaceutical safety dosage forms |
US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
BRPI0409945A (pt) * | 2003-04-30 | 2006-04-25 | Purdue Pharma Lp | forma de dosagem resistente à alteração |
US7182955B2 (en) * | 2003-04-30 | 2007-02-27 | 3M Innovative Properties Company | Abuse-resistant transdermal dosage form |
US20040219195A1 (en) * | 2003-04-30 | 2004-11-04 | 3M Innovative Properties Company | Abuse-resistant transdermal dosage form |
US8790689B2 (en) * | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
US7867511B2 (en) | 2004-01-23 | 2011-01-11 | Travanti Pharma Inc. | Abuse potential reduction in abusable substance dosage form |
SI2074989T1 (sl) * | 2004-02-23 | 2014-02-28 | Euro-Celtique S.A. | Naprava za transdermalno dajanje opioida, varna pred zlorabo |
DE102004019916A1 (de) * | 2004-04-21 | 2005-11-17 | Grünenthal GmbH | Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster |
WO2006023644A2 (en) * | 2004-08-20 | 2006-03-02 | 3M Innovative Properties Company | Transdermal drug delivery device with translucent protective film |
US7827983B2 (en) * | 2004-12-20 | 2010-11-09 | Hewlett-Packard Development Company, L.P. | Method for making a pharmaceutically active ingredient abuse-prevention device |
ES2696598T3 (es) | 2005-03-21 | 2019-01-17 | Univ Columbia | Compuestos de balanol para su uso en el tratamiento de dolor |
TWI366460B (en) | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
JP2007037868A (ja) * | 2005-08-05 | 2007-02-15 | Transcutaneous Technologies Inc | 経皮投与装置及びその制御方法 |
US20100016781A1 (en) * | 2005-08-29 | 2010-01-21 | Mizuo Nakayama | Iontophoresis device selecting drug to be administered on the basis of information form sensor |
CN101316602B (zh) | 2005-09-27 | 2015-06-03 | 组织技术公司 | 羊膜制品和纯化的组合物及其使用方法 |
US8187639B2 (en) * | 2005-09-27 | 2012-05-29 | Tissue Tech, Inc. | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment |
US20070071807A1 (en) * | 2005-09-28 | 2007-03-29 | Hidero Akiyama | Capsule-type drug-releasing device and capsule-type drug-releasing device system |
US20070078445A1 (en) * | 2005-09-30 | 2007-04-05 | Curt Malloy | Synchronization apparatus and method for iontophoresis device to deliver active agents to biological interfaces |
BRPI0619806A2 (pt) * | 2005-12-13 | 2011-10-18 | Biodelivery Sciences Int Inc | dispositivo para fornecimento de fármacos transmucosal resistente ao abuso |
TW200800223A (en) * | 2005-12-21 | 2008-01-01 | Shire Pharmaceuticals Inc | Transdermal delivery of meptazinol |
WO2008022128A2 (en) * | 2006-08-14 | 2008-02-21 | Shire Pharmaceuticals, Inc. | Transdermal delivery of meptazinol |
US7740879B2 (en) * | 2006-01-17 | 2010-06-22 | Harrogate Holdings | Abuse resistant transdermal drug delivery patch |
WO2007095586A2 (en) | 2006-02-14 | 2007-08-23 | The Trustees Of Columbia University In The City Of New York | Neuronal pain pathway modulators |
KR101486599B1 (ko) * | 2006-07-14 | 2015-01-26 | 히사미쓰 세이야꾸 가부시키가이샤 | 첩부제 |
HUE027395T2 (hu) | 2006-07-21 | 2016-10-28 | Biodelivery Sciences Int Inc | Eszközök nyálkahártyán keresztül történõ bejuttatására, javított felszívódással |
TW200838576A (en) | 2006-12-01 | 2008-10-01 | Transcu Ltd | Systems, devices and methods for powering and/or controlling transdermal delivery devices |
DE102007021549A1 (de) * | 2007-05-08 | 2008-11-13 | Novosis Ag | Transdermales therapeutisches System enthaltend mindestens zwei Opioide |
US20080286349A1 (en) * | 2007-05-18 | 2008-11-20 | Youhei Nomoto | Systems, devices, and methods for passive transdermal delivery of active agents to a biological interface |
WO2009106831A2 (en) * | 2008-02-28 | 2009-09-03 | Syntropharma Limited | Pharmaceutical composition |
TWI541246B (zh) | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
EP2421901B1 (de) | 2009-04-24 | 2015-10-28 | Tissue Tech, Inc. | Zusammensetzungen mit hc-ha-komplex und verfahren zu ihrer verwendung |
US9277748B2 (en) | 2010-03-12 | 2016-03-08 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Agonist/antagonist compositions and methods of use |
US9526770B2 (en) | 2011-04-28 | 2016-12-27 | Tissuetech, Inc. | Methods of modulating bone remodeling |
WO2012170905A1 (en) | 2011-06-10 | 2012-12-13 | Tissuetech, Inc. | Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof |
ES2660116T3 (es) | 2011-08-18 | 2018-03-20 | Biodelivery Sciences International, Inc. | Dispositivos mucoadhesivos resistentes al uso inadecuado para la administración de buprenorfina |
EP2760438B1 (de) | 2011-09-30 | 2020-01-15 | Verde Environmental Technologies, Inc. | Entsorgungssystem für transdermale pflaster, verwendungs- und herstellungsverfahren des system und kit mit dem system |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
HUE044966T2 (hu) * | 2014-01-22 | 2019-11-28 | 4P Therapeutics | Visszaélõ és nem rendeltetésszerû használatot megelõzõ transzdermális rendszerek |
TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
US10238648B2 (en) * | 2014-07-18 | 2019-03-26 | Buzzz Pharmaceuticals Ltd. | Abuse deterrent opioid/opioid-antagonist transdermal patch |
US10010543B1 (en) | 2014-12-23 | 2018-07-03 | Barr Laboratories, Inc. | Transdermal dosage form |
WO2016138025A2 (en) | 2015-02-23 | 2016-09-01 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
US20160287835A1 (en) * | 2015-04-02 | 2016-10-06 | Nogina, LLC | Method for treating angina |
JP2018516869A (ja) | 2015-05-20 | 2018-06-28 | ティッシュテック,インク. | 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法 |
US10980799B2 (en) | 2015-09-24 | 2021-04-20 | Pain Therapeutics, Inc. | Crystalline salts of naloxone and naltrexone |
TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
US11337932B2 (en) | 2016-12-20 | 2022-05-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
BR112019010466A2 (pt) | 2016-12-20 | 2019-09-10 | Lts Lohmann Therapie Systeme Ag | sistema terapêutico transdérmico contendo asenapina |
US11033512B2 (en) | 2017-06-26 | 2021-06-15 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
CN111447927A (zh) * | 2017-12-08 | 2020-07-24 | 帝国制药美国公司 | 纳洛酮经皮给药装置及其使用方法 |
US11389844B2 (en) | 2018-03-20 | 2022-07-19 | Verde Environmental Technologies, Inc. | Blister pack disposal system |
CA3101420A1 (en) | 2018-06-20 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
WO2020009685A1 (en) | 2018-07-02 | 2020-01-09 | John Tang | Transdermal dosage form |
WO2020008370A1 (en) | 2018-07-02 | 2020-01-09 | Clexio Biosciences Ltd. | Transdermal patch |
WO2020008366A1 (en) | 2018-07-02 | 2020-01-09 | Clexio Biosciences Ltd. | Transdermal dosage form |
WO2020188496A1 (en) * | 2019-03-18 | 2020-09-24 | Moshe Rogosnitzky | Stable liquid naltrexone compositions |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3527864A (en) * | 1966-11-18 | 1970-09-08 | Procter & Gamble | Compositions for topical application to animal tissue and method of enhancing penetration thereof |
US3472931A (en) * | 1969-01-17 | 1969-10-14 | Foster Milburn Co | Percutaneous absorption with lower alkyl amides |
US3903256A (en) * | 1972-02-07 | 1975-09-02 | Procter & Gamble | Compositions for topical application of animal tissue and method of enhancing penetration thereof |
US3896238A (en) * | 1972-04-05 | 1975-07-22 | Procter & Gamble | Dermatological compositions |
US3952099A (en) * | 1973-03-13 | 1976-04-20 | The Procter & Gamble Company | Dermatological compositions |
US4046886A (en) * | 1975-01-17 | 1977-09-06 | The Procter & Gamble Company | Dermatological compositions |
US4405616A (en) * | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
US3989816A (en) * | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
US4316893A (en) * | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
US4130643A (en) * | 1976-01-12 | 1978-12-19 | The Procter & Gamble Company | Dermatological compositions |
US4060084A (en) * | 1976-09-07 | 1977-11-29 | Alza Corporation | Method and therapeutic system for providing chemotherapy transdermally |
US4335115A (en) * | 1976-11-01 | 1982-06-15 | The Procter & Gamble Company | Anti-acne composition |
US4299826A (en) * | 1979-10-12 | 1981-11-10 | The Procter & Gamble Company | Anti-acne composition |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4343798A (en) * | 1981-06-23 | 1982-08-10 | The Procter & Gamble Company | Topical antimicrobial anti-inflammatory compositions |
US4560553A (en) * | 1981-07-07 | 1985-12-24 | Merck & Co., Inc. | Use of eucalyptol for enhancing skin permeation of bio-affecting agents |
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
JPS61103840A (ja) * | 1984-10-26 | 1986-05-22 | Nitto Electric Ind Co Ltd | 外皮投与用組成物 |
US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
US5066648A (en) * | 1985-11-29 | 1991-11-19 | Merck & Co., Inc. | Pyroglutamic acid esters used as dermal penetration enhancers for drugs |
US4863970A (en) * | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
US4746515A (en) * | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
US4940586A (en) * | 1987-02-26 | 1990-07-10 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US4879275A (en) * | 1987-09-30 | 1989-11-07 | Nelson Research & Development Co. | Penetration enhancers for transdermal delivery of systemic agent |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5164406A (en) * | 1988-06-02 | 1992-11-17 | Bristol-Myers Squibb Co. | Method for enhancing transdermal penetration and compositions useful therein |
US5641504A (en) * | 1988-06-09 | 1997-06-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolinoleate |
US5378730A (en) * | 1988-06-09 | 1995-01-03 | Alza Corporation | Permeation enhancer comprising ethanol and monoglycerides |
US4960771A (en) * | 1988-07-12 | 1990-10-02 | Rajadhyaksha Vithal J | Oxazolidinone penetration enhancing compounds |
US5236714A (en) * | 1988-11-01 | 1993-08-17 | Alza Corporation | Abusable substance dosage form having reduced abuse potential |
DE69009540T2 (de) * | 1989-03-15 | 1994-09-29 | Nitto Denko Corp | Arzneimittel enthaltendes Heftpflaster. |
US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
US5227169A (en) * | 1991-05-17 | 1993-07-13 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
US5326566A (en) * | 1991-05-17 | 1994-07-05 | Bristol-Myers Squibb Company | Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
US5149538A (en) * | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
US5238933A (en) * | 1991-10-28 | 1993-08-24 | Sri International | Skin permeation enhancer compositions |
US5229130A (en) * | 1991-12-20 | 1993-07-20 | Cygnus Therapeutics Systems | Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
CA2097163C (en) * | 1992-06-01 | 2002-07-30 | Marianna Foldvari | Topical patch for liposomal drug delivery system |
US5308625A (en) * | 1992-09-02 | 1994-05-03 | Cygnus Therapeutic Systems | Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters |
US6162456A (en) * | 1992-09-24 | 2000-12-19 | Ortho-Mcneil Pharmaceutical, Inc. | Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers |
JP3792252B2 (ja) * | 1993-09-29 | 2006-07-05 | アルザ・コーポレーション | オキシブチニンのためのモノグリセリド/乳酸エステル透過促進剤 |
US5420106A (en) * | 1994-03-22 | 1995-05-30 | Bristol-Myers Squibb Company | Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
US5540934A (en) * | 1994-06-22 | 1996-07-30 | Touitou; Elka | Compositions for applying active substances to or through the skin |
US5882676A (en) * | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates |
US5785991A (en) * | 1995-06-07 | 1998-07-28 | Alza Corporation | Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
EP0752421B1 (de) * | 1995-07-07 | 2005-10-12 | AstraZeneca AB | Ortho-substituierte aromatische Verbindungen, die drei (Het)aryl-Ringe enthalten, deren Herstellung und deren Verwendung als Prostaglandin-E2-(PGE2)-Antagonisten |
US5902603A (en) * | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
US5985317A (en) * | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
AU4990797A (en) * | 1996-10-24 | 1998-05-15 | Alza Corporation | Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
KR20000035801A (ko) * | 1996-10-30 | 2000-06-26 | 에버트 챨스 디 | 침투증강제로써라틱산지방산에스테르염 |
US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US5804215A (en) * | 1997-03-21 | 1998-09-08 | L. Perrigo Company | Transdermal patch disposal system and method |
UA53774C2 (uk) * | 1997-12-22 | 2003-02-17 | Еро-Селтік, С.А. | Спосіб запобігання зловживанню лікарськими формами, що містять опіоїди |
RU2241458C2 (ru) * | 1997-12-22 | 2004-12-10 | Эро-Селтик, С.А. | Комбинации агонист/антагонист опиоида |
US20040033253A1 (en) * | 2002-02-19 | 2004-02-19 | Ihor Shevchuk | Acyl opioid antagonists |
-
2003
- 2003-08-20 AT AT03749093T patent/ATE423560T1/de active
- 2003-08-20 DE DE60326354T patent/DE60326354D1/de not_active Expired - Lifetime
- 2003-08-20 JP JP2004531158A patent/JP4642467B2/ja not_active Expired - Fee Related
- 2003-08-20 WO PCT/US2003/026132 patent/WO2004017941A2/en active Application Filing
- 2003-08-20 AU AU2003268144A patent/AU2003268144A1/en not_active Abandoned
- 2003-08-20 SI SI200331577T patent/SI1530469T1/sl unknown
- 2003-08-20 DK DK03749093T patent/DK1530469T3/da active
- 2003-08-20 ES ES03749093T patent/ES2323127T3/es not_active Expired - Lifetime
- 2003-08-20 PT PT03749093T patent/PT1530469E/pt unknown
- 2003-08-20 EP EP03749093A patent/EP1530469B1/de not_active Expired - Lifetime
- 2003-08-20 US US10/645,654 patent/US20040126323A1/en not_active Abandoned
-
2009
- 2009-05-14 CY CY20091100516T patent/CY1109070T1/el unknown
-
2010
- 2010-03-09 JP JP2010051569A patent/JP5329461B2/ja not_active Expired - Fee Related
- 2010-09-30 JP JP2010220518A patent/JP5437214B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CY1109070T1 (el) | 2014-07-02 |
EP1530469B1 (de) | 2009-02-25 |
JP2010163446A (ja) | 2010-07-29 |
SI1530469T1 (sl) | 2009-06-30 |
JP4642467B2 (ja) | 2011-03-02 |
AU2003268144A8 (en) | 2004-03-11 |
WO2004017941A3 (en) | 2004-04-22 |
JP5329461B2 (ja) | 2013-10-30 |
DK1530469T3 (da) | 2009-05-04 |
AU2003268144A1 (en) | 2004-03-11 |
US20040126323A1 (en) | 2004-07-01 |
ES2323127T3 (es) | 2009-07-07 |
JP2006501241A (ja) | 2006-01-12 |
JP2011021029A (ja) | 2011-02-03 |
PT1530469E (pt) | 2009-05-19 |
EP1530469A2 (de) | 2005-05-18 |
JP5437214B2 (ja) | 2014-03-12 |
WO2004017941A2 (en) | 2004-03-04 |
ATE423560T1 (de) | 2009-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60326354D1 (de) | Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form | |
DE60320530D1 (de) | Missbrauchssichere transdermale opioid-verabreichungsvorrichtungen | |
TR200002786T2 (tr) | Meloksikam için yeni galenik bir formülasyon. | |
WO2005107726A3 (en) | Method for the treatment of back pain | |
IS8187A (is) | Meðferð á fráhvarfseinkennum | |
SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
CY1107352T1 (el) | Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου | |
DE60325965D1 (de) | Für die behandlung bzw. prevention von schmerzen geeignete triazaspiroverbindungen | |
DE60004833D1 (de) | Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung | |
TH60393A (th) | การบัดบัดรักษาอาการเจ็บปวด |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |